| First Author | Najafov A | Year | 2019 |
| Journal | Mol Cell | Volume | 75 |
| Issue | 3 | Pages | 457-468.e4 |
| PubMed ID | 31230815 | Mgi Jnum | J:281263 |
| Mgi Id | MGI:6357297 | Doi | 10.1016/j.molcel.2019.05.022 |
| Citation | Najafov A, et al. (2019) TAM Kinases Promote Necroptosis by Regulating Oligomerization of MLKL. Mol Cell 75(3):457-468.e4 |
| abstractText | Necroptosis, a cell death pathway mediated by the RIPK1-RIPK3-MLKL signaling cascade downstream of tumor necrosis factor alpha (TNF-alpha), has been implicated in many inflammatory diseases. Members of the TAM (Tyro3, Axl, and Mer) family of receptor tyrosine kinases are known for their anti-apoptotic, oncogenic, and anti-inflammatory roles. Here, we identify an unexpected role of TAM kinases as promoters of necroptosis, a pro-inflammatory necrotic cell death. Pharmacologic or genetic targeting of TAM kinases results in a potent inhibition of necroptotic death in various cellular models. We identify phosphorylation of MLKL Tyr376 as a direct point of input from TAM kinases into the necroptosis signaling. The oligomerization of MLKL, but not its membranal translocation or phosphorylation by RIPK3, is controlled by TAM kinases. Importantly, both knockout and inhibition of TAM kinases protect mice from systemic inflammatory response syndrome. In conclusion, this study discovers that immunosuppressant TAM kinases are promoters of pro-inflammatory necroptosis, shedding light on the biological complexity of the regulation of inflammation. |
